Dr. Reddy’s Stock Falls 6% Amid Revlimid Revenue Worries Despite Strong Q3 Earnings 2025
On January 24, 2025, Dr. Reddy’s Laboratories experienced a 6% decline in its stock price, despite reporting a 16% year-over-year […]
Pharma
On January 24, 2025, Dr. Reddy’s Laboratories experienced a 6% decline in its stock price, despite reporting a 16% year-over-year […]